The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara (ustekinumab).

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

Sarcopenia in the United States appears to be correlated to gallstone risk, most significantly among women, according to study results published in BMC Gastroenterology.

A new report says rice sold in US stores contains toxic heavy metals, including arsenic, cadmium, lead, and mercury.

Autoantibodies positivity was associated with a shorter time to diabetes development among children with acute and chronic pancreatitis.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.